ELSBREE DAVID B sold 5.5% of their position (5.32K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $6.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2020ACC: 0000899243-20-000700
-5.32K
Net shares
Net seller
$6.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.32K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.32K
Price / share
$1.16
Trade value
$6.17K
% of position
5.5%
1/3/2020
96.40K→91.08K
Total
Net shares
−5.32K
Net value
-$6.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2020 | S · Sale | −5.32K | $1.16 | $6.17K | 5.5% | 96.40K | 91.08K |
| Total | −5.32K | -$6.17K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10K
Total
10K indirect10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10K | Indirect |
| Total | 10K | 10K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported